US Infectious Disease Drugs Market Analysis

US Infectious Disease Drugs Market Analysis


$ 3999

US Infectious Disease Drugs Market valued at $49.87 Bn in 2023, projected to reach $58.36 Bn by 2030 with a 2.27% CAGR. The market is expanding due to the prevalence of infectious diseases, improvements in drug development, and an aging population. The market is dominated by key players like AbbVie Inc., Gilead Sciences, GlaxoSmithKline plc, Merck & Co., F. Hoffman-La Roche Ltd., Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, Novartis AG, Pfizer Inc., and Lupin Pharmaceuticals.

ID: IN10USPH012 CATEGORY: Pharmaceuticals GEOGRAPHY: US AUTHOR: Aneri Parekh

Buy Now

US Infectious Disease Drugs Market Executive Summary

US Infectious Disease Drugs Market valued at $49.87 Bn in 2023, projected to reach $58.36 Bn by 2030 with a 2.27% CAGR.

Infectious disease drugs are used to treat infections brought on by bacteria, viruses, fungi, and parasites. From common illnesses like respiratory and urinary tract infections to more serious problems like HIV/ AIDS, TB, and hepatitis, these medications are essential for managing and preventing infectious diseases. Different infectious illnesses are treated with different medication classes. Antibiotics, antivirals, antifungals, antiparasitics, and antiretrovirals are such medications. Every antibiotic class targets distinct kinds of infections and functions differently.

Rising rates of infectious diseases, rising healthcare costs, and improvements in drug research technologies are fueling the US market’s continued growth. Pharmaceutical companies are investing heavily in research and development to bring new medicines to market in response to the persistent danger of antibiotic resistance and the emergence of infectious illnesses.

With significant expansion, the global market for infectious disease drugs reached $118.75 Bn in 2023. A spike in diagnostic rates and government campaigns to increase public knowledge of infectious illness management are both responsible for this growth. The market environment is changing, as seen by a discernible rise in generic competition. Moving forward, the key to long-term growth is overcoming affordability barriers and improving treatment access, particularly in developing countries. Resolving these issues will be essential to guarantee that patients everywhere receive timely and sufficient care, which will spur additional industry innovations and developments.

Hepatitis C (HCV), HIV, and other infectious diseases are AbbVie's primary areas of focus in the US. They are working on several antiviral and antibacterial initiatives, including next-generation antibiotics for serious infections. Additionally, they take part in pro bono initiatives, investing funds in the study of remedies for illnesses that are often ignored, such as malaria, Chagas disease, and river blindness.

US infectious disease drugs market

Market Dynamics

Market Growth Drivers:

Prevalence of Infectious Diseases: One major factor driving the market is the persistence of infectious disease prevalence in the US population. There is a constant need for infectious disease medications due to conditions like HIV/ AIDS, hepatitis, tuberculosis, influenza, and new infectious diseases. 25.2 Mn cases of flu were seen in the US in 2022.

Improvements in Drug Development: Constant research and development work results in the creation of novel drugs against infectious illnesses. Progress in fields like as genomics, molecular biology, and immunology is driving the market.

Aging Population: Due to weakening immune systems and comorbidities, the aging population is more vulnerable to infectious diseases. Drugs to treat infectious are in high demand as the population ages.

Market Restraints:

Regulatory Obstacles: Rigid FDA regulations can cause delays in drug approval, which can affect a company's ability to enter the market.

High Research and Development Costs: The significant R&D costs associated with developing new medications deter investment, particularly for conditions with little commercial potential.

Generic Competition: When a patent expires, other competitors enter the market, taking market share away and driving down prices.

Healthcare Policies and Regulatory Landscape

The regulatory body in charge of overseeing pharmaceuticals in the US is the Food and Drug Administration (FDA). The FDA ensures that new drugs are safe and effective by evaluating and approving them. Pre-clinical, clinical, and FDA review are the three primary phases of the development process for most new therapeutic drugs and biologics. The process of obtaining a license for a pharmaceutical involves several difficulties, including stringent rules, costly and time-consuming development schedules, and difficulties with clinical trials.

Competitive Landscape

Key Players:

  • AbbVie Inc.
  • Gilead Sciences
  • GlaxoSmithKline plc
  • Merck & Co.
  • F. Hoffman-La Roche Ltd.
  • Boehringer Ingelheim International GmbH
  • Janssen Pharmaceuticals
  • Novartis AG
  • Pfizer Inc.
  • Lupin Pharmaceuticals

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Infectious Disease Drug Market Segmentation

By Disease

  • HIV
  • Influenza
  • Hepatitis
  • Tuberculosis
  • Malaria
  • Other

By Treatment

  • Antibacterial
  • Antiviral
  • Antiparasitic
  • Other

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 11 March 2024
Updated by: Ritu Baliya

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up